Mg2+调控BMSCs源外泌体运载miR-223-3p介导炎性微环境改变对成骨分化影响机制研究
批准号:
82060395
项目类别:
地区科学基金项目
资助金额:
34.0 万元
负责人:
龙海涛
依托单位:
学科分类:
骨、关节、软组织损伤与修复
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
龙海涛
中文摘要
对严重创伤骨折患者,尽早控制原发损伤,减少炎症的继发损伤并促进骨修复是创伤骨科医生亟待解决的问题。镁基材料及镁离子能调节炎症和促进成骨,但确切机制尚未阐明。骨髓间充质干细胞(BMSCs)可参与调节炎性微环境,是目前的研究热点。我们前期已发现镁离子上调BMSCs源外泌体中miR-223-3p表达,外泌体调节巨噬细胞NLRP3表达和极化比例,巨噬细胞极化调节成骨分化。由此提出假说:镁通过BMSCs源外泌体运载的miR-223-3p抑制巨噬细胞NLRP3炎症小体,炎症小体介导的巨噬细胞极化通过调节炎性微环境中的细胞因子促进成骨。为验证假说,本项目首先采用体外实验阐明镁离子通过BMSCs源外泌体中miR-223-3p调控巨噬细胞NLRP3炎症小体,进而明确炎症小体调控细胞因子分泌促进BMSCs成骨分化,最后采用大鼠多发骨折体内模型进行验证。为应用镁基材料救治严重创伤骨折患者提供新思路和理论依据。
英文摘要
For the treatments of patients with severe traumatic fractures, it is important and urgent for traumatic orthopedists to control the primary injury, reduce the secondary inflammatory injury and promote the bone repair as early as possible. Magnesium-based materials and magnesium ions can regulate inflammation and promote osteogenesis, but the exact mechanisms are still unclear. Bone marrow mesenchymal stem cells (BMSCs) can participate in the regulation of inflammatory microenvironment, it is a recent research hot topic. Pre-experiments found that magnesium ions increased the expression of miR-223-3p in the BMSCs-derived exosomes, the exosomes inhibited the expression of macrophage NLRP3 protein and regulated the macrophage polarization ratio, the polarized macrophages regulated the BMSCs osteogenic differentiation. Therefore, we hypothesize that magnesium ions can regulate the expression of miR-223-3p in BMSCs-derived exosomes, the miR-223-3p carried in the exosomes will inhibit the activation of NLRP3 inflammasomes, NLRP3 inflammasome-mediated macrophage polarization promotes BMSCs osteogenic differentiation by regulating cytokines in the microenvironment. To verify this hypothesis, we will firstly carry out in vitro experiments to prove that magnesium ions regulate the macrophage NLRP3 inflammasomes through miR-223-3p carried in BMSCs-derived exosomes, and then confirm that the macrophage NLRP3 inflammasomes regulate the macrophage cytokine secretion to promote BMSCs osteogenic differentiation, finally test the in vitro experiment results by animal experiments with rat multiple fractures model. The research results will provide new ideas and theoretical basis for the early application of magnesium-based materials in the treatment of severe traumatic fracture patients.
镁离子(Mg2+)是人体必需的微量元素之一,镁(Mg)金属作为21世纪的绿色金属,是工信部“十四五”规划中的重点发展领域之一,面临的机遇是前所未有的。以镁为基础构建的医用材料(镁基材料)是一类新型骨科医用材料,在临床上的应用前景广阔,但仍有许多问题亟待解决。本项目围绕着Mg2+/新型镁基材料对骨损伤修复的影响及机制开展实验,主要研究内容包括:①Mg2+调控巨噬细胞源外泌体运载miRNA调节炎性微环境并促进BMSCs成骨分化的机制研究;②镁基金属材料降解产物氢氧化镁纳米粒子(Mg(OH)2NPs)的抗菌性能及机制研究;③采用低温快速成型3D打印技术,将Mg(OH)2NPs与脱细胞骨基质微颗粒以优化比例加入到PLGA中,研发了骨微环境阶段调节支架(P80/D10/M10)并探究其对骨修复的影响和机制;④研发含Mg2+可注射型结冷水凝胶并探究其促进成骨和血管再生的性能;⑤研究镁预处理大鼠脱细胞骨支架及其促进兔桡骨骨缺损愈合的机制;⑥研究二甲双胍治疗骨质疏松骨折的分子机制、特殊病例随访、研发骨科临床新技术等。上述研究的重要结果、关键数据和研究意义如下:①阐明Mg2+通过调控巨噬细胞源外泌体中miR-381改善炎性微环境并促进BMSCs成骨的分子机制,为早期应用镁基骨折内/外固定材料救治严重创伤骨折患者提供理论依据;②证实Mg(OH)2NPs通过PI3K/Akt信号通路诱导巨噬细胞产生活性氧以杀死大肠杆菌的机制,为临床治疗骨髓炎/感染性骨缺损提供新思路;③证实P80/D10/M10支架材料在骨损伤修复的早期调节炎症,中期促进新生血管再生和后期促进骨愈合并探讨可能的分子机制;④证实含Mg2+可注射型结冷水凝胶具有促进成骨和血管再生的性能;⑤证实镁预处理脱细胞骨支架能促进兔桡骨骨缺损并揭示相关机制。上述新型镁基材料将为临床上治疗骨缺损/骨折不愈合提供新方法和理论依据。
国内基金
海外基金